Literature DB >> 12584111

Embolization by sinusoidal lining cells obstructs the microcirculation in rat sinusoidal obstruction syndrome.

Laurie D DeLeve1, Yoshiya Ito, Nancy W Bethea, Margaret K McCuskey, Xiangdong Wang, Robert S McCuskey.   

Abstract

Mechanisms leading to the obstruction of the microcirculation in sinusoidal obstruction syndrome (SOS) have been unclear. Because this occurs at the onset of disease, this is a potential key target for therapeutic intervention. Rats were treated with monocrotaline with or without continuous intraportal infusion of glutathione and were studied at 0.5, 1, 2, 4, 6, and 10 days after monocrotaline treatment with the use of in vivo microscopy and transmission electron microscopy. Sinusoidal perfusion decreased from days 1 through 10 with a nadir on day 4. At 12 h, numerous swollen sinusoidal endothelial cells (SECs) were observed. Subsequently, red blood cells penetrated into the space of Disse through gaps between and through swollen SEC and dissected the sinusoidal lining away from the parenchymal cells. Sinusoidal blood flow was obstructed by an embolism of aggregates of sinusoidal lining cells, red blood cells, and adherent monocytes. All changes were prevented by glutathione infusion, notably the initial swelling of SEC. SOS is initiated by changes in SEC. Microcirculatory obstruction is due to dissection of the sinusoidal lining, followed by embolization of the sinusoid by sinusoidal lining cells, compounded by aggregates of monocytes adherent in the sinusoids. Glutathione prevents SOS by preserving an intact sinusoidal barrier.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12584111     DOI: 10.1152/ajpgi.00526.2002

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  20 in total

1.  Prophylactic Effect of Recombinant Human Soluble Thrombomodulin for Hepatic Sinusoidal Obstruction Syndrome Model Mice.

Authors:  Shunsuke Kanou; Tomoharu Miyashita; Yasuhiko Yamamoto; Satoshi Takada; Makoto Nakura; Mitsuyoshi Okazaki; Yoshinao Ohbatake; Shinichi Nakanuma; Isamu Makino; Hidehiro Tajima; Hiroyuki Takamura; Sachio Fushida; Tetsuo Ohta
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

Review 2.  A Critical Analysis of Experimental Animal Models of Sinusoidal Obstruction Syndrome.

Authors:  Arvind Kumar; Richard Palek; Vaclav Liska
Journal:  J Clin Exp Hepatol       Date:  2018-07-17

3.  Hepatobiliary quiz (answers)-13 (2015).

Authors:  Sahaj Rathi; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2015-03-21

Review 4.  Liver sinusoidal endothelial cells and liver regeneration.

Authors:  Laurie D DeLeve
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

Review 5.  Sinusoidal obstruction syndrome (hepatic veno-occlusive disease).

Authors:  Cathy Q Fan; James M Crawford
Journal:  J Clin Exp Hepatol       Date:  2014-10-30

6.  Isolation of periportal, midlobular, and centrilobular rat liver sinusoidal endothelial cells enables study of zonated drug toxicity.

Authors:  Guanhua Xie; Lin Wang; Xiangdong Wang; Lei Wang; Laurie D DeLeve
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-09-02       Impact factor: 4.052

Review 7.  FDA-Approved Oligonucleotide Therapies in 2017.

Authors:  Cy A Stein; Daniela Castanotto
Journal:  Mol Ther       Date:  2017-03-31       Impact factor: 11.454

8.  Bone marrow progenitor cells repair rat hepatic sinusoidal endothelial cells after liver injury.

Authors:  Rula Harb; Guanhua Xie; Carolyn Lutzko; Yumei Guo; Xiangdong Wang; Colin K Hill; Gary C Kanel; Laurie D DeLeve
Journal:  Gastroenterology       Date:  2009-05-15       Impact factor: 22.682

9.  Lactoferrin protects against acetaminophen-induced liver injury in mice.

Authors:  Hao Yin; Linling Cheng; Michael Holt; Numsen Hail; Robert Maclaren; Cynthia Ju
Journal:  Hepatology       Date:  2010-03       Impact factor: 17.425

Review 10.  Liver tissue engineering in the evaluation of drug safety.

Authors:  Ajit Dash; Walker Inman; Keith Hoffmaster; Samantha Sevidal; Joan Kelly; R Scott Obach; Linda G Griffith; Steven R Tannenbaum
Journal:  Expert Opin Drug Metab Toxicol       Date:  2009-10       Impact factor: 4.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.